BIONIC PANCREASChandra Sekar.k.T.

Burden of Diabetes

Index IntroductionHistoryBi-Harmonal Automatic DeviceTechniqueAdvantagesLimitations

Introduction

Bionic Pancreas

History Dr. Edward Damiano & Dr Steven Russels of Boston University / Massachusetts General Hospital. In Year 2005 : 1st Started testing it in pigs.It is still not FDA approved. Most likely 2017 Approval

Bionic pancreas will bring the ilet to market in the name of MEDTRONiCS Mini Med 640G

Expected to launch in April 2017 after FDA approval

Components & Mechanism

Closed Loop System ControlContinuous Glucose monitorInsulin and glucagon infusion pump

Generations

Advantages It is a platform that makes a GREAT drug BETTER shared by Dr.DiaminoPast studies of automated insulin delivery have repeatedly shown that insulin needs vary dramatically from day to day and night to night

People with type 1 may require 10 units of insulin on Monday night 7 units on Tuesday 13 units on wensday Systems like Bionic Pancreas can adapt to those variations in insulin needs automatically every 5 mins in personalized insulin delivery

The bionic pancreas has some other exciting advantages Only BODY WEiGHT information is needed to begin Dosing insulin and GlucagonThe System quickly adapts with in a day to whatever specific person needs.

LimitationsLow batteriesDelayed action of subcutaneous infused insulinIncorrect adaptations of controlled algorithmsSensor unavailability due to loss of communications or non compliance of the pt.

Infusion pumpinfusion set occlusionInsulin set leakage or dislocation.Hardware/ software failuresBi harmonal systemSwitching of insulin and glucagon.

Conclusion